If there’s one big international HIV conference that’s still worth following, it’s CROI. Geoff Honnor reports on this year’s highlights. There was a time long ago, way back in the late 1990s, when the proceedings of international HIV conferences were of compelling interest to the body positive here in NSW. The biennial World AIDS Conference […]
Highlights from CROI 2016 Read More »
John Byrne was born in 1981, a few months before the U.S. Centers for Disease Control and Prevention revealed a new report about “five young, previously healthy, gay men in Los Angeles” suffering from strange infections that had already killed two of them. That was on June 5. Throughout that summer, doctors across the United
HIV conversation centers on pill that prevents transmission Read More »
The experts from the European Liver Patients Association (ELPA) Hep-CORE advisory group provide a great window on the diversity of hepatitis activity and perspectives in the region. In this series of short interviews, Hep-CORE PI Jeffrey Lazarus asked them how they came to work with viral hepatitis, how the field has been changing, and where
Let’s not forget ‘prevention as prevention’ Read More »
Look at the fact that the AIDS crisis is still not over — and then look at the ballot box for the 2016 presidential election. Look to the South, where young gay black men and Latinos are showing up at clinics at record rates. Look at prisons in Louisiana, look at what trans folks, trans
Grading the 2016 Presidential Candidates on Their HIV/AIDS Policies Read More »
Common belief is that risky behaviour is what spread hepatitis C among baby boomers (born between 1945 and 1964), but a new study indicates that is not necessarily so. If results are correct, there could be “a tsunami” of cases of this serious liver disease coming, says Dr. Julio Montaner, co-investigator and director of the
Routine medical procedures may have spread hep C Read More »
A new report indicates the hepatitis C (HCV) epidemic peaked between 1940 and 1965 with reused medical syringes to blame, not injection drug use or high risk sexual practices among baby boomers, as has often been claimed. Researchers and advocates alike hope this new information will help dispel some of the stigma attached to having
Dear Baby Boomers: Hep C Isn’t Your Fault, According to New Study Read More »
Un científico argentino estaría muy cerca de derrotar el virus del VIH/Sida. Se trata del Dr. Julio Montaner. Descubrió el “cóctel antirretroviral o de triple terapia”, la clave para transformar el manejo de la enfermedad. Montaner dedicó los últimos veinte años de su vida científica a investigar sobre el VIH/sida. Supo cómo sitiar al virus
Contra el virus HIV/SIDA Read More »
The spread of hepatitis C virus (HCV) in North America peaked between 1940 and 1965, according to research published in the March 30 advance edition of Lancet Infectious Diseases. The investigators attribute the rapid spread of the infection to hospital transmissions and reuse of medical injection equipment rather than risky behaviors such as injection drugs,
Hepatitis C Epidemic in North America Peaked Between 1940 and 1965 Read More »
The FDA has approved Descovy, a fixed-dose combination tablet containing emtricitabine and tenofovir alafenamide, for the treatment of HIV, according to the drug’s manufacturer. Descovy (emtricitabine/tenofovir alafenamide [F/TAF]; Gilead Sciences) is administered as a single oral tablet taken daily in combination with other antiretroviral agents. The formulation includes 200 mg emtricitabine and 25 mg tenofovir
FDA approves Descovy for treatment of HIV Read More »
